Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16880024 | 0.99 | SCARB1 (0.45) | SCARB1CNR2HRH1CNR1OPRD1 | |
| SCHEMBL16888558 | 0.98 | SCARB1 (0.48) | SCARB1CNR2HRH1CNR1OPRD1 | |
| Hydrochloric Acid SCHEMBL16880109 | 0.97 | SCARB1 (0.47) | SCARB1CNR2HRH1CNR1OPRD1 | |
| SCHEMBL18296928 | 0.94 | CNR1 (0.47) | SCARB1CNR2CNR1OPRD1OPRK1 | |
| Hydrochloric Acid SCHEMBL16880008 | 0.93 | CNR1 (0.46) | SCARB1CNR2CNR1OPRD1OPRK1 | |
| SCHEMBL18294867 | 0.90 | CNR2 (0.47) | SCARB1CNR2HRH1OPRK1 | |
| SCHEMBL18294836 | 0.89 | CNR2 (0.49) | SCARB1CNR2OPRK1 | |
| SCHEMBL16880206 | 0.86 | HRH1 (0.44) | SCARB1CNR2HRH1CNR1HDAC1 | |
| SCHEMBL16879926 | 0.85 | HRH1 (0.42) | SCARB1CNR2HRH1CNR1HDAC1 | |
| SCHEMBL16879907 | 0.85 | HDAC1 (0.44) | SCARB1CNR2HDAC1HDAC6AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160355475-A1 | NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2016-12-08 | — | — | US | disclosed |
| US-20160355475-A1 | NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2016-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160355475-A1 | NOVEL INDOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | HDAC2, HDAC1, HDAC3 | SCARB1 4581/4885CNR2 866/4885HRH1 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.